Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • Chapter 33 - Cervical pregnancy

  • from Section 4: - Early pregnancy after infertility treatment
  • Edited by Botros R. M. B. Rizk, University of South Alabama
  • Book:
    Ultrasonography in Reproductive Medicine and Infertility
    Published online:
    07 September 2011
    Print publication:
    25 March 2010, pp 276-282

  • Summary

    The use of transvaginal ultrasound has not only revolutionized the diagnosis of cervical pregnancy (CP) but also dramatically improved patient survival and allowed physicians to consider other fertility sparing treatment options. Management of CP depends on a number of factors. These include the gestational age, patient stability, the desire to maintain future fertility, and the available resources and expertise where the patient is managed. Generally, if the gestational age is less than 9 weeks without fetal cardiac activity, systemic chemotherapy in the form of methotrexate alone is the first line of treatment. If there is fetal heart activity and the gestational age is less than 12 weeks, intra-amniotic potassium chloride injection (3-5ml of 2 mEq/ml) should be done first, followed by systemic methotrexate. Uterine artery embolization (UAE) has been used for many years in the treatment of symptomatic uterine fibroids and in acute obstetric hemorrhage.